Pharmaceutical

Fortune highlighted Regeneron for its ability to do drug discovery for much less. To quote from their article here are the costs for drug development by some of the Big Pharma: Merck : $5.5 Billion per drug Pfizer: $7.8 Billion Sanofi: $10 Billion Average for other Pharma: $4.3 Billion Regeneron: $0.75 Billion There may be…

Drug Discovery is obviously expensive but the scientists that actually make the discoveries, make very little money. Yes, they might get a bonus or two but it is nowhere close to what the Vice President of the President of the division will make, who get a decent compensation package with stock options and other bonuses….

    Drug Discovery is expensive. Even drugs for an important disease like cancer have not been as easy to discover. There are many reasons and that could be a topic for a separate article but an MIT professor, Andrew Lo has proposed a new model. In the present model, all drug discoveries are funded…

Every company needs marketing and sales. Some it may be generated by the discussion by customers themselves but on the other hand, companies spend substantial amount of money for marketing and sales. However, marketing as its practiced is changing – the digital marketing is taking over more of the dollars as compared to the traditional…

The southeast countries and members of South Eastern Nations (ASEAN: Brunei, Burma, Cambodia, Laos, Malaysia, Singapore, Philippines, Vietnam, Indonesia and Thailand) have been working on unifying their health care systems as reported in Pharmaceutical technology in June 2013 with the link to the full article below.   There are several interesting points to note in…

Another look at the financial data of Pharmaceutical companies. Who has the big bucks to spend on research? A picture is worth a thousand words.

This question can be analyzed an-infinitum but the real answer is simple. Each of the Pharma companies here grows by their ability to research new drugs and chemical compounds. The more they spend on research, the better they will perform moving forward. The chart below is a percentage of what these companies spend on R&D…

It is surprising how few pharmaceutical companies are left that are big companies with large R&D Budgets, but the top 50 Pharma companies has very few surprises from the usual suspects. Take a look at the chart below that is derived from the Pharma Exec (link below) data. Interesting conclusions can be drawn from the…

There are several things that were considered odd by western medicine but have been proven much later to be useful. Consider these two examples: Stitches during surgery: In Kenya, Uganda and parts of South Africa, doctors or sham-doctors used ants to treat a wound. This was considered odd by western medicine. However, what is interesting…

Unlike all other modes of spectroscopy that are used in Pharma companies – for example measurement of protein or DNA the most predominant one is Raman Spectroscopy. The one technique that has been used predominantly in the Pharmaceutical companies is Raman spectroscopy. This is a relatively simple technique that is used to identify the specific…